In the week of October 27, 2025, 26 holders filed a new Schedule 13D and 130 a new Schedule 13G reporting 5% or more of a company, and 2 13D filings stated an intent to influence the company. The largest stake reported that week is Heinrich Michael's 87% of ZeroStack Corp. (Schedule 13D, October 27, 2025).
New 13D26
New 13G130
Stated intents2
The week of 2025-10-27, 26 holders filed a new Schedule 13D and 130 a new Schedule 13G reporting 5% or more of a company, and 2 13D filings stated in Item 4 an intent to influence the company. Open a company for every holder and the purpose each 13D states, quoted.
New Schedule 13D
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2025-10-27 | ZeroStack Corp. | Heinrich Michael | 87% | SCHEDULE 13D |
| 2025-10-29 | Rent the Runway, Inc. | CHS US Investments LLC | 59.9% | SCHEDULE 13D |
| 2025-10-27 | Perpetuals.com Ltd | North York Ltd | 24.7% | SCHEDULE 13D |
| 2025-10-27 | Palomino Laboratories Inc. | Shealy Jeffrey B. | 23.8% | SCHEDULE 13D |
| 2025-10-31 | Endovia Health Sciences, Inc. | Fore Thomas Butler | 23.7% | SCHEDULE 13D |
| 2025-10-27 | Harvard Ave Acquisition Corporation | Copley Square LLC | 21.1% | SCHEDULE 13D |
| 2025-10-28 | Minerva Neurosciences Inc | Federated Hermes, Inc. | 19.32% | SCHEDULE 13D |
| 2025-10-27 | Bonk, Inc. | Lucky Dog Holdings | 19.2% | SCHEDULE 13D |
| 2025-10-31 | Origin Agritech Limited | Agriflag Company Limited | 19.06% | SCHEDULE 13D |
| 2025-10-29 | Lafayette Acquisition Corp | LaFayette Sponsor LLC | 17.86% | SCHEDULE 13D |
| 2025-10-28 | Figma, Inc. | Dylan Field | 17.8% | SCHEDULE 13D |
| 2025-10-28 | Calisa Acquisition Corp | Gai Na | 17.4% | SCHEDULE 13D |
| 2025-10-29 | Bioceres Crop Solutions Corp. | Agriculture Investment Group Corp. | 17.05% | SCHEDULE 13D |
| 2025-10-29 | Rent the Runway, Inc. | STORY3 Capital Partners, LLC | 12.8% | SCHEDULE 13D |
| 2025-10-29 | Rent the Runway, Inc. | Nexus Capital Management LP | 12.8% | SCHEDULE 13D |
| 2025-10-30 | Prospect Enhanced Yield Fund | Eliasek M Grier | 12.8% | SCHEDULE 13D |
| 2025-10-29 | GeoPark Limited | Parex Resources Inc. intent stated | 11.8% | SCHEDULE 13D |
| 2025-10-29 | Promis Neurosciences Inc. | ABG Management Ltd. | 11.3% | SCHEDULE 13D |
| 2025-10-30 | Rani Therapeutics Holdings, Inc. | Samsara BioCapital, L.P. | 9.9% | SCHEDULE 13D |
| 2025-10-28 | Calisa Acquisition Corp | Zhang Dahe | 8.6% | SCHEDULE 13D |
| 2025-10-29 | InspireMD, Inc. | Michael A. Lawless | 8.6% | SCHEDULE 13D |
| 2025-10-30 | Alaunos Therapeutics, Inc. | Price Adrian | 8.6% | SCHEDULE 13D |
| 2025-10-27 | Harvard Ave Acquisition Corporation | Northlake Partners Ltd. | 7.8% | SCHEDULE 13D |
| 2025-10-27 | Endovia Health Sciences, Inc. | Nistico Robert | 7.1% | SCHEDULE 13D |
| 2025-10-30 | Catalyst Bancorp, Inc. | Stilwell Joseph | 5.2% | SCHEDULE 13D |
| 2025-10-27 | Trilogy Metals Inc. | Tony Giardini | 5% | SCHEDULE 13D |
New Schedule 13G
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2025-10-27 | Eagle Point Trinity Senior Secured Lending Company | EPH Investments LLC | 83% | SCHEDULE 13G |
| 2025-10-27 | 707 Cayman Holdings Limited | JME International Holdings Limited | 59.27% | SCHEDULE 13G |
| 2025-10-29 | Virax Biolabs Group Limited | James Foster | 24.9% | SCHEDULE 13G |
| 2025-10-31 | Rise Gold Corp. | Abdiel Capital Advisors, LP | 19.99% | SCHEDULE 13G |
| 2025-10-27 | Eagle Point Trinity Senior Secured Lending Company | Trinity Capital Inc. | 17% | SCHEDULE 13G |
| 2025-10-28 | Nexentis Technologies Inc. | Alon Silberman | 16.93% | SCHEDULE 13G |
| 2025-10-28 | Figma, Inc. | Dylan Field | 16% | SCHEDULE 13G |
| 2025-10-28 | BlackRock Fund Advisors | Public Employees Retirement System Of Ohio | 15.1% | SCHEDULE 13G |
| 2025-10-28 | C3is Inc. | Athanasios Tsiakmakis | 14.36% | SCHEDULE 13G |
| 2025-10-30 | Easterly Government Properties Inc | The Vanguard Group | 10.28% | SCHEDULE 13G |
| 2025-10-28 | INVO Fertility, Inc. | Greenblock Capital, LLC | 9.99% | SCHEDULE 13G |
| 2025-10-30 | ENDRA Life Sciences Inc. | John Carter Lipman | 9.99% | SCHEDULE 13G |
| 2025-10-27 | XORTX Therapeutics Inc. | Lincoln Alternative Strategies LLC | 9.9% | SCHEDULE 13G |
| 2025-10-27 | Citius Pharmaceuticals, Inc. | CVI Investments, Inc. | 9.9% | SCHEDULE 13G |
| 2025-10-28 | ENDRA Life Sciences Inc. | ATW Master Fund V LP | 9.9% | SCHEDULE 13G |
| 2025-10-30 | Rani Therapeutics Holdings, Inc. | RA Capital Management, L.P. | 9.9% | SCHEDULE 13G |
| 2025-10-27 | iPower Inc. | White Cherry Limited | 9.8% | SCHEDULE 13G |
| 2025-10-27 | Alto Neuroscience Inc | Commodore Capital LP | 9.8% | SCHEDULE 13G |
| 2025-10-31 | Neuphoria Therapeutics Inc. | Baselake Partners, LP | 9.4% | SCHEDULE 13G |
| 2025-10-30 | Centuri Holdings Inc | The Vanguard Group | 9.09% | SCHEDULE 13G |
| 2025-10-27 | Quoin Pharmaceuticals Ltd. | Integrated Core Strategies (US) LLC | 9% | SCHEDULE 13G |
| 2025-10-31 | First Trust Exchange-Traded Fund VIII | First Trust Portfolios L.P. | 8.97% | SCHEDULE 13G |
| 2025-10-30 | Liberty Capital Corporation | The Vanguard Group | 8.84% | SCHEDULE 13G |
| 2025-10-30 | DT Cloud Star Acquisition Corporation | Feis Equities LLC | 8.77% | SCHEDULE 13G |
| 2025-10-31 | Perpetua Resources Corp. | Agnico Eagle Mines Limited | 8.71% | SCHEDULE 13G |
| 2025-10-30 | Liberty Capital Corporation | The Vanguard Group | 8.55% | SCHEDULE 13G |
| 2025-10-29 | Lakefront Biotherapeutics NV | Tang Capital Management, LLC | 8.4% | SCHEDULE 13G |
| 2025-10-27 | AI Financial Corp | Crcm LP | 8.2% | SCHEDULE 13G |
| 2025-10-31 | Hims & Hers Health Inc | Jpmorgan Chase & Co. | 8.1% | SCHEDULE 13G |
| 2025-10-31 | Endovia Health Sciences, Inc. | Tong Magdalene | 7.7% | SCHEDULE 13G |
| 2025-10-29 | Tenax Therapeutics Inc | Point72 Asset Management, L.P. | 7.4% | SCHEDULE 13G |
| 2025-10-29 | Rapt Therapeutics, Inc. | ForGrowth III PA B.V. | 7.4% | SCHEDULE 13G |
| 2025-10-31 | Netskope, Inc. | The Vanguard Group | 7.36% | SCHEDULE 13G |
| 2025-10-31 | Neuphoria Therapeutics Inc. | Shay Capital LLC | 7.3% | SCHEDULE 13G |
| 2025-10-29 | Central & Eastern Europe Fund, Inc. | Phronesis Partners, L.P. | 7.2% | SCHEDULE 13G |
| 2025-10-27 | Lexeo Therapeutics, Inc. | RA Capital Management, L.P. | 6.9% | SCHEDULE 13G |
| 2025-10-29 | CapsoVision, Inc | CID Greater China Venture Capital Fund III, L.P. | 6.7% | SCHEDULE 13G |
| 2025-10-31 | Luminar Technologies, Inc. | The Vanguard Group | 6.62% | SCHEDULE 13G |
| 2025-10-31 | NYLIM MacKay DefinedTerm Muni Opportunities Fund | First Trust Portfolios L.P. | 6.43% | SCHEDULE 13G |
| 2025-10-29 | Harvard Ave Acquisition Corporation | Millennium Management LLC | 6.4% | SCHEDULE 13G |
| 2025-10-31 | VanEck Oil Refiners ETF | First Trust Portfolios L.P. | 6.37% | SCHEDULE 13G |
| 2025-10-31 | Tonix Pharmaceuticals Holding Corp. | The Vanguard Group | 6.35% | SCHEDULE 13G |
| 2025-10-28 | Angel Oak Mortgage REIT, Inc. | Victory Capital Management, Inc. | 6.06% | SCHEDULE 13G |
| 2025-10-31 | Western Asset Managed Municipals Fund Inc. | First Trust Portfolios L.P. | 6.04% | SCHEDULE 13G |
| 2025-10-31 | Bold Eagle Acquisition Corp. | Harraden Circle Investments, LLC | 6.02% | SCHEDULE 13G |
| 2025-10-31 | Powell Industries, Inc. | First Trust Portfolios L.P. | 5.93% | SCHEDULE 13G |
| 2025-10-30 | Aebi Schmidt Holding Ag | Pzena Investment Management LLC | 5.9% | SCHEDULE 13G |
| 2025-10-29 | Flowco Holdings Inc | Encompass Capital Advisors LLC | 5.85% | SCHEDULE 13G |
| 2025-10-29 | Flowco Holdings Inc | Encompass Capital Advisors LLC | 5.85% | SCHEDULE 13G |
| 2025-10-29 | CalciMedica, Inc. | Bering Partners II, L.P. ("Bering II") | 5.8% | SCHEDULE 13G |
| 2025-10-30 | Lake Superior Acquisition Corp | Feis Equities LLC | 5.71% | SCHEDULE 13G |
| 2025-10-27 | Nextdoor Holdings Inc | Sumitomo Mitsui Trust Group, Inc. | 5.7% | SCHEDULE 13G |
| 2025-10-28 | Tiziana Life Sciences Ltd | Laura Natalia Monica Fonda | 5.7% | SCHEDULE 13G |
| 2025-10-28 | Comerica Inc | Bank of New York Mellon Corp | 5.7% | SCHEDULE 13G |
| 2025-10-30 | Eagle Financial Services Inc | The Vanguard Group | 5.7% | SCHEDULE 13G |
| 2025-10-31 | Cslm Digital Asset Acquisition Corp Iii, Ltd | Jpmorgan Chase & Co. | 5.7% | SCHEDULE 13G |
| 2025-10-31 | OptimizeRx Corp | The Vanguard Group | 5.7% | SCHEDULE 13G |
| 2025-10-31 | OneSpan Inc | First Trust Portfolios L.P. | 5.63% | SCHEDULE 13G |
| 2025-10-29 | First Trust Exchange-Traded Fund Iii | First Trust Portfolios L.P. | 5.62% | SCHEDULE 13G |
| 2025-10-31 | Tempus AI, Inc. | The Vanguard Group | 5.59% | SCHEDULE 13G |
| 2025-10-30 | AI Financial Corp | The Vanguard Group | 5.58% | SCHEDULE 13G |
| 2025-10-30 | ServiceTitan Inc | The Vanguard Group | 5.55% | SCHEDULE 13G |
| 2025-10-31 | Metsera, Inc. | The Vanguard Group | 5.53% | SCHEDULE 13G |
| 2025-10-28 | Chord Energy Corp | Victory Capital Management, Inc. | 5.47% | SCHEDULE 13G |
| 2025-10-29 | Bioceres Crop Solutions Corp. | Agriculture Investment Group Corp. | 5.47% | SCHEDULE 13G |
| 2025-10-30 | Intrepid Potash Inc. | The Vanguard Group | 5.45% | SCHEDULE 13G |
| 2025-10-31 | United Parks & Resorts Inc. | The Vanguard Group | 5.44% | SCHEDULE 13G |
| 2025-10-30 | American Vanguard Corporation | The Vanguard Group | 5.41% | SCHEDULE 13G |
| 2025-10-29 | iShares MSCI Japan Value ETF | First Trust Portfolios L.P. | 5.35% | SCHEDULE 13G |
| 2025-10-31 | Trump Media & Technology Group Corp | The Vanguard Group | 5.35% | SCHEDULE 13G |
| 2025-10-30 | Root, Inc. | The Vanguard Group | 5.32% | SCHEDULE 13G |
| 2025-10-29 | First Trust Exchange-Traded Fund VIII | First Trust Portfolios L.P. | 5.31% | SCHEDULE 13G |
| 2025-10-30 | Annexon Inc | The Vanguard Group | 5.31% | SCHEDULE 13G |
| 2025-10-31 | Kodiak Gas Services Inc | The Vanguard Group | 5.31% | SCHEDULE 13G |
| 2025-10-29 | Mayville Engineering Co Inc | Hilve Holdings Ltd | 5.3% | SCHEDULE 13G |
| 2025-10-30 | Amrize Ltd | The Vanguard Group | 5.3% | SCHEDULE 13G |
| 2025-10-30 | Heritage Insurance Holdings, Inc. | The Vanguard Group | 5.3% | SCHEDULE 13G |
| 2025-10-30 | Infleqtion, Inc. | Kenneth Griffin | 5.3% | SCHEDULE 13G |
| 2025-10-31 | Hayward Holdings Inc | Jpmorgan Chase & Co. | 5.3% | SCHEDULE 13G |
| 2025-10-31 | Ventyx Biosciences, Inc. | The Vanguard Group | 5.28% | SCHEDULE 13G |
| 2025-10-31 | Soleno Therapeutics, Inc. | The Vanguard Group | 5.28% | SCHEDULE 13G |
| 2025-10-30 | Repay Holdings Corporation | The Vanguard Group | 5.27% | SCHEDULE 13G |
| 2025-10-30 | Avalo Therapeutics Inc | The Vanguard Group | 5.26% | SCHEDULE 13G |
| 2025-10-30 | Groupon, Inc. | The Vanguard Group | 5.21% | SCHEDULE 13G |
| 2025-10-31 | Terns Pharmaceuticals, Inc. | The Vanguard Group | 5.21% | SCHEDULE 13G |
| 2025-10-29 | Werner Enterprises Inc | First Trust Portfolios L.P. | 5.2% | SCHEDULE 13G |
| 2025-10-30 | Amprius Technologies, Inc. | The Vanguard Group | 5.2% | SCHEDULE 13G |
| 2025-10-31 | Solid Power, Inc. | The Vanguard Group | 5.2% | SCHEDULE 13G |
| 2025-10-28 | Dole plc | Victory Capital Management, Inc. | 5.19% | SCHEDULE 13G |
| 2025-10-28 | Nnn Reit Inc | Victory Capital Management, Inc. | 5.17% | SCHEDULE 13G |
| 2025-10-30 | Kearny Financial Corp | The Vanguard Group | 5.17% | SCHEDULE 13G |
| 2025-10-30 | Intuitive Machines, Inc. | The Vanguard Group | 5.16% | SCHEDULE 13G |
| 2025-10-31 | West BanCorp Inc | The Vanguard Group | 5.16% | SCHEDULE 13G |
| 2025-10-30 | Granite Point Mortgage Trust Inc | The Vanguard Group | 5.15% | SCHEDULE 13G |
| 2025-10-30 | Energy Fuels Inc | The Vanguard Group | 5.15% | SCHEDULE 13G |
| 2025-10-30 | The Realreal, Inc | The Vanguard Group | 5.14% | SCHEDULE 13G |
| 2025-10-30 | Ring Energy Inc | The Vanguard Group | 5.13% | SCHEDULE 13G |
| 2025-10-28 | Cool Company Ltd. | JNE Partners LLP | 5.12% | SCHEDULE 13G |
| 2025-10-31 | The Vita Coco Company, Inc. | The Vanguard Group | 5.12% | SCHEDULE 13G |
| 2025-10-29 | Nuveen Real Asset Income and Growth Fund | First Trust Portfolios L.P. | 5.11% | SCHEDULE 13G |
| 2025-10-27 | Keros Therapeutics, Inc. | D. E. Shaw & Co., L.P. | 5.1% | SCHEDULE 13G |
| 2025-10-27 | Ibotta, Inc. | Sumitomo Mitsui Trust Group, Inc. | 5.1% | SCHEDULE 13G |
| 2025-10-29 | Compass Therapeutics, Inc. | Bvf Partners L P | 5.1% | SCHEDULE 13G |
| 2025-10-29 | First Trust Exchange-Traded Fund VIII | First Trust Portfolios L.P. | 5.1% | SCHEDULE 13G |
| 2025-10-30 | Creative Realities, Inc. | Lytton Laurence W | 5.1% | SCHEDULE 13G |
| 2025-10-30 | Tavia Acquisition Corp. | Tenor Capital Management Company, L.P. | 5.1% | SCHEDULE 13G |
| 2025-10-31 | Post Holdings Inc | Jpmorgan Chase & Co. | 5.1% | SCHEDULE 13G |
| 2025-10-30 | Beta Bionics, Inc. | The Vanguard Group | 5.09% | SCHEDULE 13G |
| 2025-10-30 | Frontview Reit Inc | The Vanguard Group | 5.08% | SCHEDULE 13G |
| 2025-10-30 | Abeona Therapeutics Inc. | The Vanguard Group | 5.07% | SCHEDULE 13G |
| 2025-10-29 | First Trust Exchange-Traded Fund VII | First Trust Portfolios L.P. | 5.06% | SCHEDULE 13G |
| 2025-10-30 | Century Casinos Inc | The Vanguard Group | 5.06% | SCHEDULE 13G |
| 2025-10-30 | Perma Fix Environmental Services Inc | The Vanguard Group | 5.06% | SCHEDULE 13G |
| 2025-10-29 | Highland Opportunities & Income Fund | Thomas J. Herzfeld Advisors, Inc. | 5.05% | SCHEDULE 13G |
| 2025-10-31 | Niagen Bioscience, Inc. | The Vanguard Group | 5.04% | SCHEDULE 13G |
| 2025-10-30 | Brookfield Infrastructure Corp | The Vanguard Group | 5.03% | SCHEDULE 13G |
| 2025-10-30 | BV Financial Inc | The Vanguard Group | 5.03% | SCHEDULE 13G |
| 2025-10-31 | News Corp | The Vanguard Group | 5.03% | SCHEDULE 13G |
| 2025-10-31 | TruBridge, Inc. | The Vanguard Group | 5.03% | SCHEDULE 13G |
| 2025-10-31 | TPG RE Finance Trust Inc | The Vanguard Group | 5.03% | SCHEDULE 13G |
| 2025-10-29 | OKYO Pharma Ltd | Laura Natalia Monica Fonda | 5.01% | SCHEDULE 13G |
| 2025-10-30 | Ceco Environmental Corp | The Vanguard Group | 5.01% | SCHEDULE 13G |
| 2025-10-30 | Eton Pharmaceuticals, Inc. | The Vanguard Group | 5.01% | SCHEDULE 13G |
| 2025-10-30 | Peoples Bancorp Of North Carolina Inc | The Vanguard Group | 5.01% | SCHEDULE 13G |
| 2025-10-29 | BayCom Corp | Bay Pond Partners, L.P. | 5% | SCHEDULE 13G |
| 2025-10-30 | Arrivent Biopharma Inc | The Vanguard Group | 5% | SCHEDULE 13G |
| 2025-10-30 | Idaho Strategic Resources Inc | The Vanguard Group | 5% | SCHEDULE 13G |
| 2025-10-30 | INVE Technologies, Inc. | The Vanguard Group | 5% | SCHEDULE 13G |
| 2025-10-30 | RBB Bancorp (RBB) | The Vanguard Group | 5% | SCHEDULE 13G |
| 2025-10-31 | Smith Douglas Homes Corp | The Vanguard Group | 5% | SCHEDULE 13G |
Stated intent
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2025-10-29 | GeoPark Limited | Parex Resources Inc. intent stated | 11.8% | SCHEDULE 13D |
| 2025-10-31 | Carver Bancorp Inc | Mann Barry James intent stated | 7.2% | SCHEDULE 13D/A |
Download this data (CSV)158 rows, with sources. Free with an account.
Tools for this story
Each opens in a new tab. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.